We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy


SCIEX presents Extraordinary Grace

Video   May 25, 2021


Join forces to share the future of science. Be part of a movement shining a light on identity, opportunity and inclusion.

As scientists, we are the very experts in discovering answers, but by missing out on invaluable, diverse perspectives, we’re missing out on crucial thinking that has the potential to unlock a new era of scientific greatness.

Introducing Grace, a young girl with an extraordinary future. Grace represents the next generation of scientists, but also, the underrepresented. She has the potential to change the face of analytical science; hers is an incredible, but fragile journey that calls upon your unique expertise for mentorship.

Grace will face many barriers as she grows up, but is unprepared for the challenges along the way, finding herself frequently asking a life-defining question:

“Should I continue with a career in science?”

By sharing your unique perspective and experiences with Grace, you’ll be joining an unprecedented conversation in science, where together, we can form an extensive, truly accurate picture of our industry.

Now, wouldn’t that be extraordinary.

INSPIRE GRACE and TAKE THE SURVEY: https://sciex.com/grace-csm

#BeExtraordinary #ExtraordinaryGrace

More Information

Request Information


Recommended Videos

Potential Therapeutic Uses of Cannabinoids With Professor Roger Pertwee


Much of what we know about the cannabis plant and its effects on the human body has only been formally discovered in the past 60 years. A good deal of these pioneering investigations have involved today's Teach Me in 10 guest: Roger Pertwee, an emeritus professor at the University of Aberdeen.


How To Tackle Global Inequities in Cancer


Cancer can affect everybody, but not equally. Certain people, whether because of their gender, race, education or socioeconomic status see worse outcomes from cancer. Access to cancer screening can differ, as well as the quality of patients’ lives after treatment.


Amersham™ brand ImageQuant™ 800 GxP biomolecular imager – Cytiva


Sensitive, flexible CCD-based imagers designed to support FDA 21 CFR Part 11 EU GMP Annex 11 regulations



Like what you just watched? You can find similar content on the communities below.

Analysis & Separations Applied Sciences Biopharma Cancer Research Diagnostics Drug Discovery Genomics Research Informatics Proteomics & Metabolomics Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free